High throughput metabolic stability screen for lead optimization in drug discovery

Area of Science:

• Pharmacology
• Drug Discovery
• Biotechnology

Background:

• Drug discovery requires efficient methods to assess metabolic stability and profiles of new chemical entities.
• Traditional methods can be time-consuming and may not meet the demands of high throughput screening.
• Understanding in vitro metabolic fate is crucial for selecting viable drug candidates early in the development pipeline.

Purpose of the Study:

• To develop and validate a high throughput approach for determining in vitro metabolic stability and profiles of drug candidates.
• To integrate automated liquid handling and incubation for streamlined microsome stability studies.
• To provide a user-friendly system for efficient data processing and report generation in early drug discovery.

Main Methods:

• Utilized a Biomek FX liquid handling system with 96-channel pipetting.
• Incorporated a custom-designed 96-well format on-line incubator with efficient thermal conductivity.
• Developed a user-friendly computer program for large-scale data processing and report generation.

Main Results:

• The developed approach enables automated reagent preparation, sample incubation, and sample purification.
• The system demonstrated speed and accuracy, suitable for high throughput screening demands.
• Facilitated rapid selection of compounds in early drug discovery through efficient data handling.

Conclusions:

• The integrated automated system offers a fast and accurate solution for in vitro metabolic stability and profiling.
• This high throughput approach effectively addresses the challenges of early drug discovery screening.
• The strategy supports the rapid selection of promising drug candidates, optimizing the discovery process.